Thanks for joining DividendStocks.com, the daily newsletter built for dividend and income investors like you. We’re thrilled to have you on board and can’t wait to help you discover the best dividend opportunities out there. Before we can start sending your daily insights, please take a quick moment to confirm your subscription: Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Why wait? Let’s get your dividend journey started! Click Here to Start Discovering Top Income-Generating Stocks See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Today's Bonus Story Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025By Leo Miller. Posted: 1/3/2026. 
What You Need to Know - While small caps as a whole generated lower returns than large caps in 2025, three interesting names bucked this narrative.
- A cancer screening company and two satellite operators saw their shares rise 300% or more.
- See where analysts are forecasting upside and understand vital considerations pertaining to smaller stocks.
In 2025, small-cap stocks broadly underperformed. The Russell 2000 Index, which tracks 2,000 U.S. small-cap stocks, returned roughly 13% for the year — well below the S&P 500's total return of about 18%, which tracks U.S. large-cap stocks. Despite that lag, three names stood out for exceptional performance in 2025. Below, we detail three stocks that returned 300% or more. This analysis focuses on companies that began 2025 in small-cap territory but, thanks to their gains, have since moved into mid-cap range. GRAIL Catapults on Early Cancer Detection Enthusiasm A former hedge fund manager known for cutting through market noise is briefly opening access to his flagship trading strategy. In a short demo, he explains how his "One Ticker" approach works — and how readers can access the full service for a year at a steep discount. Watch the brief demo here Healthcare stock GRAIL (NASDAQ: GRAL) climbed roughly 380% in 2025. Its market capitalization rose from well under $1 billion to about $3.3 billion. GRAIL's primary product is the Galleri multi-cancer early detection test. Early detection substantially improves cancer survival, which has driven investor interest in Galleri. Only about five cancer types currently have standardized screening methods, yet roughly 70% of cancer deaths stem from other cancers. Galleri was designed to detect more than 50 cancer types. In a recent study, GRAIL reported that adding Galleri to traditional screening increased early cancer detection by more than sevenfold. Today, most Galleri sales come from out-of-pocket payments. GRAIL plans to apply for Premarket Approval (PMA) from the U.S. Food and Drug Administration in the first quarter of 2026; if approved, commercial insurers would be far more likely to cover the test, opening a potentially large new sales channel. That potential approval is a major factor behind investor enthusiasm. The MarketBeat consensus price target of $97.50 reflects analyst optimism and implies roughly 14% upside from current levels. PL Blasts Off, Combining AI with Geospatial Imagery Planet Labs PBC (NYSE: PL) enjoyed a blockbuster 2025, with shares rising just under 390%. The company operates hundreds of satellites that capture medium- to high-resolution imagery of Earth, and it pairs that data with artificial intelligence to help customers make decisions. Planet generates revenue through subscriptions to its cloud-based platform and satellite services. Demand is materializing, particularly from government customers. Its Dec. 10 earnings report propelled shares up about 35% in a day; defense and intelligence revenue rose more than 70%. The company reported a backlog near $735 million — roughly 2.6 times its trailing 12 months' revenue of $282 million — suggesting room for substantial growth. Planet Labs also posted positive free cash flow for the second consecutive quarter. The MarketBeat consensus price target of $14.74 implies about 25% downside, but the average of targets updated after the company's latest earnings report is $18.19, which implies roughly 7.7% downside. Planet Labs remains a name to watch; a meaningful pullback could create a more attractive entry point. Updated Targets Eye Strong Upside in VSAT After Huge 2025 Run Last is Viasat (NASDAQ: VSAT), which gained about 305% in 2025 and now has a market cap near $4.7 billion. Like Planet Labs, Viasat is a satellite company, but it focuses on internet and data connectivity rather than primarily serving consumer telecom operators. Viasat's customers include aviation, maritime and government clients. Viasat provides in-flight wireless connectivity to thousands of commercial and business aircraft. The U.S. government was its largest customer in fiscal 2025, accounting for 18% of revenue (the company is currently in fiscal 2026). Revenues grew just 2% last quarter, but awards increased 17% to nearly $1.5 billion and backlog climbed to nearly $3.9 billion. The MarketBeat consensus price target of $32.75 implies roughly 5% downside. However, analyst targets updated after the Nov. 7 earnings report average $49, suggesting about 37% upside. GRAIL, Planet Labs, VSAT: Deep Research Is Paramount Overall, GRAIL, Planet Labs and Viasat delivered remarkable returns in 2025. These stocks are compelling, but smaller companies that have posted very large gains can be highly volatile and carry elevated risk. Investors should have conviction in each company's long-term prospects and perform thorough due diligence before making investment decisions.
| 
